Sucampo Pharmaceuticals to be acquired in $1.2B deal

By December 26, 2017News

Global pharmaceutical company Mallinckrodt Plc (NYSE: MNK) has entered an agreement to buy Rockville’s Sucampo Pharmaceuticals Inc. (NASDAQ: SCMP) for $1.2 billion including debt.

View Original Article »

Join our Mailing List